Telehealth holds the promise of increasing access to care. But research findings concerning direct-to-consumer (DTC) telehealth, reported in JAMA Network Open last month, suggest that it might not be as simple as that.
Telehealth holds the promise of increasing access to care. But research findings concerning direct-to-consumer (DTC) telehealth, reported in JAMA Network Open last month, suggest that it might not be as simple as that.
Ateev Mehrotra, M.D., M.P.H., an associate professor of health policy and medicine at Harvard Medical School and a member of Managed Healthcare Executive®’s editorial advisory board, and Tara Jain, M.D., MBA, a physician at Brigham and Women’s Hospital in Boston, conducted a cross-sectional study of telehealth usage by using de-
identified data from a DTC telehealth company (they don’t name the company). The company’s services were available in 20 states, and the data Mehrotra and Jain used in the analysis were for about 35,000 visits between Oct. 1, 2019, and Dec. 31, 2019. Comparing the telehealth users with the overall population in those states, the researchers found that the telehealth patients were more likely to live in urban areas and high-income ZIP codes. Only 14.4% of the visits
were for patients living in areas identified as having a shortage
of primary care.
When Mehrotra and Jain looked at why people used the company’s services, they found that 87% of the visits were for one of three conditions: urinary tract infections (53%), erectile dysfunction (21%) and contraception (13%).
Mehrotra and Jain put barriers to access into different categories and suggest that their findings indicate that DTC telehealth helps with some barriers (accommodation barriers having to do with convenience and acceptability barriers having to do with embarrassment about sexual issues) but not others (clinician availability or affordability barriers). “Those seem like important barriers, and telehealth isn’t addressing them,” Mehrotra said.
But Mehrotra also stressed that “telehealth” is an umbrella term: “DTC is just one distinct form of telehealth,” he said. “In this application, the advantage was the convenience and avoidance of embarrassment. I think that is an important finding, but there are many other forms of telehealth.”
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift | AIDS 2024
July 25th 2024Phase 3 trials reported at the International AIDS Society meeting this week show no infections among those randomly assigned to twice-year injections of lenacapavir and no reason to be worried about safety,.
Read More